Holen Sie sich die Stockscreener-App
32.13
5.37%
-0.39
Schlusskurs vom Vortag:
$32.52
Offen:
$31
24-Stunden-Volumen:
26,346
Relative Volume:
0.80
Marktkapitalisierung:
$1.40B
Einnahmen:
$9.74M
Nettoeinkommen (Verlust:
$7.19M
KGV:
196.27
EPS:
0.1637
Netto-Cashflow:
$2.25M
1W Leistung:
-4.84%
1M Leistung:
+12.52%
6M Leistung:
+36.23%
1J Leistung:
+299.68%
1-Tages-Spanne:
$30.10
$33.87
1-Wochen-Bereich:
$28.71
$35.50
52-Wochen-Spanne:
$7.50
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Compare NNNN vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
31.80 | 1.43B | 9.74M | 7.19M | 2.25M | 0.1637 |
ISRG
Intuitive Surgical Inc
|
437.65 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
148.91 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.72 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.13 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.64 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten
Assessing Anbio Biotechnology (NNNN) Valuation After Strong Recent Share Price Momentum - simplywall.st
Why Anbio Biotechnology Shares Are Tumbling Now - TipRanks
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
Anbio Biotechnology Shareholders Approve Sweeping Capital and Governance Changes - TipRanks
Control shifts as Anbio (NNNN) boosts Class B voting power - Stock Titan
Why Anbio Biotechnology Shares Won’t Stop Climbing - TipRanks
Uncovering 3 Undiscovered Gems in the US Market - Yahoo Finance
TradingKey - TradingKey
Number of shareholders of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Why are smart money investors paying attention to Anbio (NNNN)? (Momentum Fading) 2026-05-07Overvalued Stocks - Newser
Why Anbio Biotechnology Class A Shares Are Jumping - TipRanks
Free cash flow per share of Anbio Biotechnology Class A – FWB:N3B - TradingView
Anbio Biotechnology Calls May 15 Shareholder Votes on Sweeping Capital and Governance Overhaul - The Globe and Mail
Anbio Biotechnology (NNNN) seeks huge capital increase and 500-vote Class B shares - Stock Titan
Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat
Why Anbio Biotechnology Shares Are Suddenly Surging - TipRanks
Anbio (NNNN) Stock Volume Drop (Buying Pressure) 2026-04-22Volatility Surface - Newser
Anbio Biotechnology posts solid FY25 results, diversifies portfolio - MSN
Cany Xu Net Worth (2026) - GuruFocus
Nancy Hartzler Net Worth (2026) - GuruFocus
Suki Song Net Worth (2026) - GuruFocus
Michael Lau Net Worth (2026) - GuruFocus
Chris Tian Net Worth (2026) - GuruFocus
Why Anbio Biotechnology Shares Are Sliding Fast - TipRanks
Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.5%Here's What Happened - MarketBeat
Assessing Anbio Biotechnology (NNNN) Valuation After Sharp Swings And A Rich Price To Book Multiple - simplywall.st
Anbio Biotechnology Broadens Test Portfolio And Shifts Risk Profile - Sahm
Is Anbio (NNNN) Stock Discounted Now | Price at $27.63, Up 1.96%Large Cap Trends - Newser
Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio - Sahm
Is Anbio (NNNN) Stock Good for Beginners | Price at $26.77, Down 0.28%Viral Momentum Stocks - Newser
Form 20-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] - ADVFN
Discovering US Undiscovered Gems for April 2026 - simplywall.st
Anbio Biotechnology (NNNN) files 20-F/A to mark well-known seasoned issuer - Stock Titan
Anbio Biotechnology (ANBF) Non Cash 74.1% Net Margin Fuels Fresh Debate On Earnings Quality - simplywall.st
Anbio Biotechnology | 3: Initial statement of beneficial ownership of securities- Hartzler Nancy - Moomoo
Anbio Biotechnology (NNNN) CEO Michael Lau identified as insider in Form 3 - Stock Titan
Anbio Biotechnology (NNNN) director XU CANY files initial Form 3 - Stock Titan
Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks
Super-voting control and post-COVID shift at Anbio Biotechnology (Nasdaq: NNNN) - Stock Titan
Anbio Biotechnology Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Will Anbio (NNNN) Stock Hit New Highs | Price at $26.40, Up 2.13%Open Market Insights - Newser
Exxon Mobil, Pepsico among market cap stock movers on Monday - Investing.com UK
Exxon Mobil, Pepsico among market cap stock movers on Monday By Investing.com - Investing.com Canada
Anbio Biotechnology (NNNN) Surges 11.6% Intraday – What’s Fueling the Volatility? - Bitget
Finanzdaten der Anbio Biotechnology-Aktie (NNNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):